YBX1 and cholangiocarcinoma: In cholangiocarcinoma patients, the m5C-modified functional lncRNA NKILA (NF-kappa B interacting lncRNA), which is recognized and stabilized by YBX1, is associated with advanced TNM stage and poor prognosis (103).